Wellgistics Health (NASDAQ:WGRX) Issues Earnings Results

Wellgistics Health (NASDAQ:WGRXGet Free Report) released its quarterly earnings data on Friday. The company reported ($0.13) earnings per share (EPS) for the quarter, Zacks reports. Wellgistics Health had a negative net margin of 228.17% and a negative return on equity of 1,617.25%. The business had revenue of $1.67 million during the quarter.

Wellgistics Health Trading Up 14.3%

Shares of WGRX stock opened at $0.14 on Friday. The company has a current ratio of 0.39, a quick ratio of 0.16 and a debt-to-equity ratio of 1.86. Wellgistics Health has a 12-month low of $0.11 and a 12-month high of $7.04. The stock has a market capitalization of $12.29 million and a P/E ratio of -0.10. The firm’s 50 day moving average is $0.28 and its 200 day moving average is $0.57.

Hedge Funds Weigh In On Wellgistics Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Raymond James Financial Inc. boosted its stake in shares of Wellgistics Health by 593.8% in the 3rd quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock worth $52,000 after buying an additional 50,000 shares during the last quarter. Geode Capital Management LLC increased its position in Wellgistics Health by 81.0% during the fourth quarter. Geode Capital Management LLC now owns 487,383 shares of the company’s stock valued at $195,000 after acquiring an additional 218,170 shares during the last quarter. Finally, XTX Topco Ltd increased its position in Wellgistics Health by 195.1% during the fourth quarter. XTX Topco Ltd now owns 106,087 shares of the company’s stock valued at $42,000 after acquiring an additional 70,137 shares during the last quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Wellgistics Health in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Wellgistics Health presently has an average rating of “Sell”.

Get Our Latest Research Report on Wellgistics Health

About Wellgistics Health

(Get Free Report)

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.

See Also

Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.